Express Scripts 2014 Annual Report Download - page 53

Download and view the complete annual report

Please find page 53 of the 2014 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 116

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116

51
Express Scripts 2014 Annual Report
INCOME TAXES
ACCOUNTINGPOLICY
Deferredtaxassetsandliabilitiesarerecordedbasedontemporarydifferencesbetweenthefinancialstatement
basisandthetaxbasisofassetsandliabilitiesusingpresentlyenactedtaxrates.Weevaluatetaxpositionstodeterminewhether
thebenefitsoftaxpositionsaremorelikelythannotofbeingsustaineduponauditbasedonthetechnicalmeritsofthetax
position.
FACTORSAFFECTINGESTIMATE
Thefactorsthatcouldimpactourestimatesofuncertaintaxpositionsareasfollows:
• likelihoodofbeingsustaineduponauditbasedonthetechnicalmeritsofthetaxposition
• assumedinterestandpenaltiesassociatedwithuncertaintaxpositions
OTHER ACCOUNTING POLICIES
Weconsiderthefollowinginformationaboutrevenuerecognitionpoliciesimportantforanunderstandingofour
resultsofoperations:
PRESCRIPTIONDRUGREVENUES
Revenuesfromthesaleofprescriptiondrugsbyretailpharmaciesarerecognizedwhentheclaimisprocessed.
Whenweindependentlyhaveacontractualobligationtopayournetworkpharmacyprovidersforbenefitsprovidedtoour
clients’members,weactasaprincipalinthearrangementandweincludethetotalprescriptionprice(ingredientcostplus
dispensingfee)wehavecontractedwiththeseclientsasrevenue,includingmemberco-paymentstopharmacies.
Revenuesfromdispensingprescriptionsfromourhomedeliveryandspecialtypharmaciesarerecordedwhen
prescriptionsareshipped.Theserevenuesincludetheco-paymentreceivedfrommembersofthehealthplansweserve.Atthe
timeofshipment,wehaveperformedsubstantiallyallofourobligationsunderthecustomercontractsanddonotexperiencea
significantlevelofreshipmentsorreturns.
Whenwemerelyadministeraclient’snetworkpharmacycontractstowhichwearenotapartyandunderwhichwe
donotassumecreditrisk,weearnanadministrativefeeforcollectingpaymentsfromtheclientandremittingthecorresponding
amounttothepharmaciesintheclient’snetwork.Inthesetransactions,drugingredientcostisnotincludedinourrevenuesor
inourcostofrevenues.
REBATESANDADMINISTRATIVEFEES
Grossrebatesandadministrativefeesearnedfortheadministrationofourrebateprograms,performedin
conjunctionwithclaimsprocessingservicesprovidedtoclients,arerecordedasareductionofcostofrevenuesandtheportion
oftherebatepayabletocustomersistreatedasareductionofrevenues.
Whenweearnrebatesandadministrativefeesinconjunctionwithformularymanagementservices,butdonot
processtheunderlyingclaims,werecordrebatesreceivedfrommanufacturers,netoftheportionpayabletocustomers,in
revenues.
MEDICAREPRESCRIPTIONDRUGPROGRAM
OurrevenuesincludepremiumsassociatedwithourMedicarePartDPrescriptionDrugProgram(“PDP”)risk-
basedproductofferings.TheseproductsinvolveprescriptiondrugdispensingforbeneficiariesenrolledinMedicarePartD
planssponsoredbyuspursuanttoourcontractswiththeCentersforMedicare&MedicaidServices(“CMS”).Inadditionto
MedicarePartDPDPpremiums,therearecertainco-paymentsanddeductibles(the“costshare”)duefrommembersbasedon
prescriptionordersbythosemembers,someofwhicharesubsidizedbyCMSincasesoflow-incomemembership.Ourcostof
revenuesincludesthecostofdrugsdispensedbyourhomedeliverypharmaciesorretailnetworkformemberscoveredunder
ourMedicarePartDPDPproductofferingsandisrecordedatcostasincurred.
47